Abstract
Background: Aim of this study was to establish the method yielding the highest sensitivity routinely used to determine fetal RhD type and gender from maternal cell‐free plasma DNA in different periods of gestation.
Methods: Plasma DNA concentrations were measured from 46 pregnant women in different gestational periods and tested for RhD using three different PCR methods on exon 7: Thermal Cycler, Taqman method on LightCycler, and melting curve analysis on LightCycler. In addition, fetal gender was determined by PCR. Cell‐free plasma DNA was measured in 100 healthy volunteers as a reference group.
Results: The mean value of cell‐free plasma DNA in the reference group was 10.9 pg/µL mean, (standard deviation (SD): 3.66) in 50 healthy women and 12.7 pg/µL (SD: 8.2) in 50 healthy men. In the firsttrimester of pregnancy cell‐free plasmaDNA was 14.9 pg/µL mean, (SD: 4.2), in the second trimester 15.4 pg/µL mean, (SD: 4.96), and the maximum was achieved in the third trimester of pregnancy 15.6 pg/µl mean, (SD: 6.49). TaqMan probes had the same accuracy, when compared with Thermal Cycler technology (46 samples, 6 failures). Using real‐time PCR with melting curve analysis 12 of 17 samples were correctly tested. Gender determination was correctly in 41 of 46 samples.
Conclusion: RhD determinations with TaqMan and Thermal Cycler technology are useful methods for fetal RhD prediction. To increase the accuracy of RhD determination it is necessary to test on other exons in addition. J. Clin. Lab. Anal. 23:24–28, 2009. © 2009 Wiley‐Liss, Inc.
Keywords: fetal RhD, plasma DNA, PCR, cell‐free DNA
REFERENCES
- 1. Ulm B, Svolba G, Ulm MR, Bernaschek G, Panzer S. Male fetuses are particularly affected by maternal alloimmunization to D antigen. Transfusion 1999;39:169–173. [DOI] [PubMed] [Google Scholar]
- 2. Pertl B, Pieber D, Panzitt T, et al. RhD genotyping by quantitative fluorescent polymerase chain reaction: a new approach. BJOG 2000;107:1498–1502. [DOI] [PubMed] [Google Scholar]
- 3. Cotorruelo C, Biondi C, Garcia Borras S, Di Monaco R, Racca A. Early detection of RhD status in pregnancies at risk of hemolytic disease of the newborn. Clin Exp Med 2002;2:77–81. [DOI] [PubMed] [Google Scholar]
- 4. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485–487. [DOI] [PubMed] [Google Scholar]
- 5. Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 2004;1022:119–123. [DOI] [PubMed] [Google Scholar]
- 6. Bianchi DW, Lo YM. Fetomaternal cellular and plasma DNA trafficking: The Yin and the Yang. Ann N Y Acad Sci 2001;945:119–131. [DOI] [PubMed] [Google Scholar]
- 7. Bischoff FZ, Nguyen DD, Marquez‐Do D, Moise KJ Jr, Simpson JL, Elias S. Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR. J Soc Gynecol Investig 1999;6:64–69. [DOI] [PubMed] [Google Scholar]
- 8. Siva SC, Johnson SI, McCracken SA, Morris JM. Evaluation of the clinical usefulness of isolation of fetal DNA from the maternal circulation. Aust N Z J Obstet Gynaecol 2003;43:10–15. [DOI] [PubMed] [Google Scholar]
- 9. Geifman‐Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood—a meta‐analysis. Am J Obstet Gynecol 2006;195:1163–1173. [DOI] [PubMed] [Google Scholar]
- 10. Grootkerk‐Tax MG, Soussan AA, de Haas M, Maaskant‐van Wijk PA, van der Schoot CE. Evaluation of prenatal RHD typing strategies on cell‐free fetal DNA from maternal plasma. Transfusion 2006;46:2142–2148. [DOI] [PubMed] [Google Scholar]
- 11. Clausen FB, Krog GR, Rieneck K, et al. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Prenat Diagn 2005;25:1040–1044. [DOI] [PubMed] [Google Scholar]
- 12. Krog GR, Clausen FB, Dziegiel MH. Quantitation of RHD by real‐time polymerase chain reaction for determination of RHD zygosity and RHD mosaicism/chimerism: an evaluation of four quantitative methods. Transfusion 2007;47:715–722. [DOI] [PubMed] [Google Scholar]
- 13. Hromadnikova I, Vechetova L, Vesela K, et al. Non‐invasive fetal RHD exon 7 and exon 10 genotyping using real‐time PCR testing of fetal DNA in maternal plasma. Fetal Diagn Ther 2005;20:275–280. [DOI] [PubMed] [Google Scholar]